The recent application of novel technologies to the robot-assisted radical prostatectomy (RARP) procedure has provided a new perspective and demonstrated potential usefulness in surgical planning, intraoperative navigation, and education of both patients and healthcare professionals, allowing for a patient-tailored prostate cancer (PCa) treatment. Integration of novel techniques into robotic surgery has improved the accuracy of surgery and has demonstrated a potential benefit in functional and oncological outcomes in patients with PCa. However, furtherrandomized and prospective studies are needed to assess and validate the role of these technologies in clinical practice. The aim of this review is to summarize the current evidence on the new emerging techniques, such as three-dimensional (3D) imaging and printing, augmented reality (AR), and confocal microscopy (CM), and their impact on RARP and its oncological outcomes.
Improving oncological outcomes after robotassisted radical prostatectomy: what novel tools do we have? / Dilme, R. V.; Rivas, J. G.; Hernandez, L. F.; Vazquez, L. I.; Cacciamani, G. E.; Puliatti, S.; Taratkin, M.; Checcucci, E.; Belenchon, I. R.; Kowalewski, K. -F.; Serrano, A.; Moreno-Sierra, J.. - In: MINI-INVASIVE SURGERY. - ISSN 2574-1225. - 6:(2022), pp. 1-4. [10.20517/2574-1225.2022.48]
Improving oncological outcomes after robotassisted radical prostatectomy: what novel tools do we have?
Puliatti S.;
2022
Abstract
The recent application of novel technologies to the robot-assisted radical prostatectomy (RARP) procedure has provided a new perspective and demonstrated potential usefulness in surgical planning, intraoperative navigation, and education of both patients and healthcare professionals, allowing for a patient-tailored prostate cancer (PCa) treatment. Integration of novel techniques into robotic surgery has improved the accuracy of surgery and has demonstrated a potential benefit in functional and oncological outcomes in patients with PCa. However, furtherrandomized and prospective studies are needed to assess and validate the role of these technologies in clinical practice. The aim of this review is to summarize the current evidence on the new emerging techniques, such as three-dimensional (3D) imaging and printing, augmented reality (AR), and confocal microscopy (CM), and their impact on RARP and its oncological outcomes.File | Dimensione | Formato | |
---|---|---|---|
5212_down.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
504.43 kB
Formato
Adobe PDF
|
504.43 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris